Skip to main content
Utility
Give
Search
Menu
Close
Main navigation
About the Department
toggle sub nav items
Message from the Chair
Leadership
Culture, Engagement, and Community
Quality and Innovation
Achievements & Recognition
History
Giving
Careers
Map and Directions
Contact Us
Divisions
toggle sub nav items
Cardiology
Endocrinology, Metabolism, and Nutrition
Gastroenterology
General Internal Medicine
Geriatrics and Palliative Care
Hematologic Malignancies and Cellular Therapy
Hematology
Hospital Medicine
Infectious Diseases
Medical Oncology
Nephrology
Pulmonary, Allergy, and Critical Care Medicine
Rheumatology and Immunology
Faculty
toggle sub nav items
Academic Affairs
Faculty Development
Professionalism
Patient Care
toggle sub nav items
Referrals
In the Community
Research
toggle sub nav items
Publications
Research Strategic Plan
Basic and Translational Research
Clinical Research
Duke Institutes and Centers
Research Administration
Research Laboratories
Research Resources
Research Development Council
Grants and Funding
Scholarly Culture and Accountability
Education and Training
toggle sub nav items
Internal Medicine Residency
Fellowship Programs
Medical Student Education
Training Sites
Our Trainees
Trainee Career Development
About Duke and Durham
News
toggle sub nav items
Calendar of Events
Annual Reports
Utility
Give
Home
News
Comparative Study of Two Heart Failure Drugs Finds No Difference in Outcomes
November 2, 2022
Share
